Tag peripheral t-cell lymphoma

Home » peripheral t-cell lymphoma

Ruth Alonso-Alonso, PhD

Researcher Spotlight: Ruth Alonso-Alonso, PhD THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK Oliver W. Press, MD, PhD Memorial Fellow Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive form of peripheral T-cell lymphoma. Therapeutic options for AITL are…

Wen-Hsuan Wendy Lin, MD, PhD

Researcher Spotlight: Wen-Hsuan Wendy Lin, MD, PhD COLUMBIA UNIVERSITY Peripheral T-cell lymphomas (PTCL) represent a group of aggressive blood cancers with poor outcomes. A common phenomenon in PTCL is the development of a proinflammatory microenvironment, in which lymphoma cells recruit…

Zachary Epstein-Peterson, MD

Researcher Spotlight: Zachary Epstein-Peterson, MD MEMORIAL SLOAN KETTERING CANCER CENTER Peripheral T-cell lymphomas are a rare and challenging group of malignancies to treat. Mutations in the isocitrate dehydrogenase 2 (IDH2) enzyme have been identified in a subgroup of patients with…

A Clinical Trial Saved My Life

Clinical Trials are important to helping advance research and provide access to the most cutting-edge treatment options. Rich Zavadowski felt a clinical trial was his best chance of survival when he was diagnosed with Stage IV peripheral T-cell lymphoma (PTCL) - a rare subtype of lymphoma with no standard of care.

Neha Mehta-Shah, MD

Researcher Spotlight: Neha Mehta-Shah, MD Washington University in Saint Louis Peripheral T-cell lymphomas (PTCL) are a rare group of lymphomas that are commonly treated with combination chemotherapy, followed by autologous stem cell transplant for patients with a good response. However,…